| Peter J Oberley, PHARMD | |
|
515 22nd Ave, Monroe, WI 53566-1598 | |
| (608) 324-2000 | |
| Not Available |
| Full Name | Peter J Oberley |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 515 22nd Ave, Monroe, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316588213 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 20079-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peter J Oberley, PHARMD 1325 16th St Apt 3, Monroe, WI 53566-2451 Ph: (262) 744-4288 | Peter J Oberley, PHARMD 515 22nd Ave, Monroe, WI 53566-1598 Ph: (608) 324-2000 |
News Archive
The Lancet examines the domestic health positions of President Barack Obama and Republican presidential nominee Mitt Romney before briefly outlining their positions on global health.
The plan includes a variety of executive actions which touch the health care system, including clarifications that the health law does not prohibit doctors asking their patients about guns in their homes and that no federal law prohibits health care providers from reporting threats of violence to law-enforcement authorities.
The New York Times reports that standards are being developed to protect consumers' choices of doctors and hospitals under the health law's new insurance plans. Also, the Wall Street Journal checks in on how the ranks of the uninsured are reacting to the overhaul.
A new study from Karolinska Institutet in Sweden finds that testing for human papilloma virus (HPV) allows for longer time between screening tests when compared to cytology-based testing. The study is published in the scientific journal British Medical Journal (BMJ).
Celgene Corporation and Abraxis BioScience Inc. today jointly announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Abraxis BioScience. Under the terms of the merger agreement, each share of Abraxis BioScience common stock will be converted into the right to receive an upfront payment of $58.00 in cash and 0.2617 shares of Celgene common stock.
› Verified 7 days ago
Nicole Lyn Carrico, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Anna Metz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Michael Kuckes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 W 8th St, Monroe, WI 53566 Phone: 608-325-3310 | |
Kathryn Kirmse, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1008 17th Ave, Monroe, WI 53566 Phone: 608-325-2151 Fax: 608-325-2153 | |
Dr. Stephanie Marie Garvin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2259 | |
Kent B Pieper, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Ms. Barbara Marie Cappel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-325-3111 Fax: 608-324-2439 |